AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 288: E1137-E1145, 2005; doi:10.1152/ajpendo.00356.2004
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moesgaard, S. G.
Right arrow Articles by Gram, D. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moesgaard, S. G.
Right arrow Articles by Gram, D. X.

Sensory nerve inactivation by resiniferatoxin improves insulin sensitivity in male obese Zucker rats

Sophia G. Moesgaard,1,2 Christian L. Brand,1 Jeppe Sturis,1 Bo Ahrén,3 Michael Wilken,1 Jan Fleckner,1 Richard D. Carr,1 Ove Svendsen,2 Anker J. Hansen,1 and Dorte X. Gram1,2

1Discovery, Novo Nordisk A/S, Maaloev; 2Department of Pharmacology and Pathobiology, The Royal Veterinary and Agricultural University, Copenhagen, Denmark; and 3Department of Medicine, Lund University, Lund, Sweden

Submitted 4 August 2004 ; accepted in final form 9 January 2005

Recent studies have suggested that sensory nerves may influence insulin secretion and action. The present study investigated the effects of resiniferatoxin (RTX) inactivation of sensory nerves (desensitization) on oral glucose tolerance, insulin secretion and whole body insulin sensitivity in the glucose intolerant, hyperinsulinemic, and insulin-resistant obese Zucker rat. After RTX treatment (0.05 mg/kg RTX sc given at ages 8, 10, and 12 wk), fasting plasma insulin was reduced (P < 0.0005), and oral glucose tolerance was improved (P < 0.005). Pancreas perfusion showed that baseline insulin secretion (7 mM glucose) was lower in RTX-treated rats (P = 0.01). Insulin secretory responsiveness to 20 mM glucose was enhanced in the perfused pancreas of RTX-treated rats (P < 0.005) but unaffected in stimulated, isolated pancreatic islets. At the peak of spontaneous insulin resistance in the obese Zucker rat, insulin sensitivity was substantially improved after RTX treatment, as evidenced by higher glucose infusion rates (GIR) required to maintain euglycemia during a hyperinsulinemic euglycemic (5 mU·kg–1·min–1) clamp (GIR60–120min: 5.97 ± 0.62 vs. 11.65 ± 0.83 mg·kg–1·min–1 in RTX-treated rats, P = 0.003). In conclusion, RTX treatment and, hence, sensory nerve desensitization of adult male obese Zucker rats improved oral glucose tolerance by enhancing insulin secretion, and, in particular, by improving insulin sensitivity.

capsaicin; hyperinsulinemic euglycemic clamp; obesity


Address for reprint requests and other correspondence: D. X. Gram, Pharmacology Research 3, Novo Nordisk A/S, Novo Nordisk Park, F6.1.30, 2760 Maaloev, Denmark (E-mail: dxg{at}novonordisk.com)




This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Ferrari, M. Arnold, R. D. Carr, W. Langhans, G. Pacini, T. B. Bodvarsdottir, and D. X. Gram
Subdiaphragmatic vagal deafferentation affects body weight gain and glucose metabolism in obese male Zucker (fa/fa) rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1027 - R1034.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.